| Title: | Nonlinear Mixed Effects Models in Population PK/PD, Data | 
| Version: | 2.0.9 | 
| Description: | Datasets for 'nlmixr2' and 'rxode2'. 'nlmixr2' is used for fitting and comparing nonlinear mixed-effects models in differential equations with flexible dosing information commonly seen in pharmacokinetics and pharmacodynamics (Almquist, Leander, and Jirstrand 2015 <doi:10.1007/s10928-015-9409-1>). Differential equation solving is by compiled C code provided in the 'rxode2' package (Wang, Hallow, and James 2015 <doi:10.1002/psp4.12052>). | 
| License: | GPL (≥ 3) | 
| Encoding: | UTF-8 | 
| RoxygenNote: | 7.2.3 | 
| Depends: | R (≥ 2.10) | 
| LazyData: | true | 
| BugReports: | https://github.com/nlmixr2/nlmixr2data/issues/ | 
| URL: | https://nlmixr2.github.io/nlmixr2data/, https://github.com/nlmixr2/nlmixr2data/ | 
| NeedsCompilation: | no | 
| Packaged: | 2024-01-31 19:55:55 UTC; matt | 
| Author: | Matthew Fidler  | 
| Maintainer: | Matthew Fidler <matthew.fidler@gmail.com> | 
| Repository: | CRAN | 
| Date/Publication: | 2024-01-31 20:40:02 UTC | 
1 Compartment Model Simulated Data from ACOP 2016
Description
This is a simulated dataset from the ACOP 2016 poster. All Datasets were simulated with the following methods.
Usage
Bolus_1CPT
Format
A data frame with 7,920 rows and 14 columns
- ID
 Simulated Subject ID
- TIME
 Simulated Time
- DV
 Simulated Dependent Variable
- LNDV
 Simulated log(Dependent Variable)
- MDV
 Missing DV data item
- AMT
 Dosing AMT
- EVID
 NONMEM Event ID
- DOSE
 Dose
- V
 Individual Simulated Volume
- CL
 Individual Clearance
- SS
 Steady State
- II
 Interdose Interval
- SD
 Single Dose Flag
- CMT
 Compartment
Details
Richly sampled profiles were simulated for 4 different dose levels (10, 30, 60 and 120 mg) of 30 subjects each as single dose (over 72h), multiple dose (4 daily doses), single and multiple dose combined, and steady state dosing, for a range of test models: 1- and 2-compartment disposition, with and without 1st order absorption, with either linear or Michaelis-Menten (MM) clearance(MM without steady state dosing). This provided a total of 42 test cases. All inter-individual variabilities (IIVs) were set at 30%, residual error at 20% and overlapping PK parameters were the same for all models. A similar set of models was previously used to compare NONMEM and Monolix4. Estimates of population parameters, standard errors for fixed-effect parameters, and run times were compared both for closed-form solutions and using ODEs. Additionally, a sparse data estimation situation was investigated where 500 datasets of 600 subjects each (150 per dose) were generated consisting of 4 random time point samples in 24 hours per subject, using a first-order absorption, 1-compartment disposition, linear elimination model.
Source
Schoemaker R, Xiong Y, Wilkins J, Laveille C, Wang W. nlmixr2: an open-source package for pharmacometric modelling in R. ACOP 2016
See Also
Other nlmixr2 datasets: 
Bolus_1CPTMM,
Bolus_2CPTMM,
Bolus_2CPT,
Infusion_1CPTMM,
Infusion_1CPT,
Infusion_2CPTMM,
Infusion_2CPT,
Oral_1CPTMM,
Oral_1CPT,
Oral_2CPTMM,
Oral_2CPT,
Wang2007,
mavoglurant,
nimoData,
nmtest,
pheno_sd,
rats,
theo_md,
theo_sd,
warfarin,
wbcSim
1 Compartment Model w/ Michaelis-Menten Elimination
Description
This is a simulated dataset from the ACOP 2016 poster. All Datasets were simulated with the following methods.
Usage
Bolus_1CPTMM
Format
A data frame with 7,920 rows and 14 columns
- ID
 Simulated Subject ID
- TIME
 Simulated Time
- DV
 Simulated Dependent Variable
- LNDV
 Simulated log(Dependent Variable)
- MDV
 Missing DV data item
- AMT
 Dosing AMT
- EVID
 NONMEM Event ID
- DOSE
 Dose
- V
 Individual Simulated Volume
- VM
 Individual Vm constant
- KM
 Individual Km constant
- SD
 Single Dose Flag
- CMT
 Compartment
Details
Richly sampled profiles were simulated for 4 different dose levels (10, 30, 60 and 120 mg) of 30 subjects each as single dose (over 72h), multiple dose (4 daily doses), single and multiple dose combined, and steady state dosing, for a range of test models: 1- and 2-compartment disposition, with and without 1st order absorption, with either linear or Michaelis-Menten (MM) clearance(MM without steady state dosing). This provided a total of 42 test cases. All inter-individual variabilities (IIVs) were set at 30%, residual error at 20% and overlapping PK parameters were the same for all models. A similar set of models was previously used to compare NONMEM and Monolix4. Estimates of population parameters, standard errors for fixed-effect parameters, and run times were compared both for closed-form solutions and using ODEs. Additionally, a sparse data estimation situation was investigated where 500 datasets of 600 subjects each (150 per dose) were generated consisting of 4 random time point samples in 24 hours per subject, using a first-order absorption, 1-compartment disposition, linear elimination model.
Source
Schoemaker R, Xiong Y, Wilkins J, Laveille C, Wang W. nlmixr2: an open-source package for pharmacometric modelling in R. ACOP 2016
See Also
Other nlmixr2 datasets: 
Bolus_1CPT,
Bolus_2CPTMM,
Bolus_2CPT,
Infusion_1CPTMM,
Infusion_1CPT,
Infusion_2CPTMM,
Infusion_2CPT,
Oral_1CPTMM,
Oral_1CPT,
Oral_2CPTMM,
Oral_2CPT,
Wang2007,
mavoglurant,
nimoData,
nmtest,
pheno_sd,
rats,
theo_md,
theo_sd,
warfarin,
wbcSim
2 Compartment Model
Description
This is a simulated dataset from the ACOP 2016 poster. All Datasets were simulated with the following methods.
Usage
Bolus_2CPT
Format
A data frame with 7,920 rows and 16 columns
- ID
 Simulated Subject ID
- TIME
 Simulated Time
- DV
 Simulated Dependent Variable
- LNDV
 Simulated log(Dependent Variable)
- MDV
 Missing DV data item
- AMT
 Dosing AMT
- EVID
 NONMEM Event ID
- DOSE
 Dose
- V1
 Individual Central Compartment Volume
- CL
 Individual Clearance
- Q
 Individual Between Compartment Clearance
- V2
 Periperial Volume
- SS
 Steady State Flag
- II
 Interdose interval
- SD
 Single Dose Flag
- CMT
 Compartment Indicator
Details
Richly sampled profiles were simulated for 4 different dose levels (10, 30, 60 and 120 mg) of 30 subjects each as single dose (over 72h), multiple dose (4 daily doses), single and multiple dose combined, and steady state dosing, for a range of test models: 1- and 2-compartment disposition, with and without 1st order absorption, with either linear or Michaelis-Menten (MM) clearance(MM without steady state dosing). This provided a total of 42 test cases. All inter-individual variabilities (IIVs) were set at 30%, residual error at 20% and overlapping PK parameters were the same for all models. A similar set of models was previously used to compare NONMEM and Monolix4. Estimates of population parameters, standard errors for fixed-effect parameters, and run times were compared both for closed-form solutions and using ODEs. Additionally, a sparse data estimation situation was investigated where 500 datasets of 600 subjects each (150 per dose) were generated consisting of 4 random time point samples in 24 hours per subject, using a first-order absorption, 1-compartment disposition, linear elimination model.
Source
Schoemaker R, Xiong Y, Wilkins J, Laveille C, Wang W. nlmixr2: an open-source package for pharmacometric modelling in R. ACOP 2016
See Also
Other nlmixr2 datasets: 
Bolus_1CPTMM,
Bolus_1CPT,
Bolus_2CPTMM,
Infusion_1CPTMM,
Infusion_1CPT,
Infusion_2CPTMM,
Infusion_2CPT,
Oral_1CPTMM,
Oral_1CPT,
Oral_2CPTMM,
Oral_2CPT,
Wang2007,
mavoglurant,
nimoData,
nmtest,
pheno_sd,
rats,
theo_md,
theo_sd,
warfarin,
wbcSim
2 Compartment Model with Michaelis-Menten Clearance
Description
This is a simulated dataset from the ACOP 2016 poster. All Datasets were simulated with the following methods.
Usage
Bolus_2CPTMM
Format
A data frame with 7,920 rows and 15 columns
- ID
 Simulated Subject ID
- TIME
 Simulated Time
- DV
 Simulated Dependent Variable
- LNDV
 Simulated log(Dependent Variable)
- MDV
 Missing DV data item
- AMT
 Dosing AMT
- EVID
 NONMEM Event ID
- DOSE
 Dose
- V
 Individual Central Compartment Volume
- VM
 Individual Vmax
- KM
 Individual Km
- Q
 Individual Q
- V2
 Individual Peripheral Compartment Volume
- SD
 Single Dose Flag
- CMT
 Compartment Indicator
Details
Richly sampled profiles were simulated for 4 different dose levels (10, 30, 60 and 120 mg) of 30 subjects each as single dose (over 72h), multiple dose (4 daily doses), single and multiple dose combined, and steady state dosing, for a range of test models: 1- and 2-compartment disposition, with and without 1st order absorption, with either linear or Michaelis-Menten (MM) clearance(MM without steady state dosing). This provided a total of 42 test cases. All inter-individual variabilities (IIVs) were set at 30%, residual error at 20% and overlapping PK parameters were the same for all models. A similar set of models was previously used to compare NONMEM and Monolix4. Estimates of population parameters, standard errors for fixed-effect parameters, and run times were compared both for closed-form solutions and using ODEs. Additionally, a sparse data estimation situation was investigated where 500 datasets of 600 subjects each (150 per dose) were generated consisting of 4 random time point samples in 24 hours per subject, using a first-order absorption, 1-compartment disposition, linear elimination model.
Source
Schoemaker R, Xiong Y, Wilkins J, Laveille C, Wang W. nlmixr2: an open-source package for pharmacometric modelling in R. ACOP 2016
See Also
Other nlmixr2 datasets: 
Bolus_1CPTMM,
Bolus_1CPT,
Bolus_2CPT,
Infusion_1CPTMM,
Infusion_1CPT,
Infusion_2CPTMM,
Infusion_2CPT,
Oral_1CPTMM,
Oral_1CPT,
Oral_2CPTMM,
Oral_2CPT,
Wang2007,
mavoglurant,
nimoData,
nmtest,
pheno_sd,
rats,
theo_md,
theo_sd,
warfarin,
wbcSim
1 Compartment Model Simulated Data from ACOP 2016
Description
This is a simulated dataset from the ACOP 2016 poster. All Datasets were simulated with the following methods.
Usage
Infusion_1CPT
Format
A data frame with 7,920 rows and 14 columns
- ID
 Simulated Subject ID
- TIME
 Simulated Time
- DV
 Simulated Dependent Variable
- LNDV
 Simulated log(Dependent Variable)
- MDV
 Missing DV data item
- AMT
 Dosing AMT
- EVID
 NONMEM Event ID
- DOSE
 Dose
- V
 Individual Simulated Volume
- CL
 Individual Clearance
- SS
 Steady State
- II
 Interdose Interval
- SD
 Single Dose Flag
- RATE
 NONMEM Rate
- CMT
 Compartment
Details
Richly sampled profiles were simulated for 4 different dose levels (10, 30, 60 and 120 mg) of 30 subjects each as single dose (over 72h), multiple dose (4 daily doses), single and multiple dose combined, and steady state dosing, for a range of test models: 1- and 2-compartment disposition, with and without 1st order absorption, with either linear or Michaelis-Menten (MM) clearance(MM without steady state dosing). This provided a total of 42 test cases. All inter-individual variabilities (IIVs) were set at 30%, residual error at 20% and overlapping PK parameters were the same for all models. A similar set of models was previously used to compare NONMEM and Monolix4. Estimates of population parameters, standard errors for fixed-effect parameters, and run times were compared both for closed-form solutions and using ODEs. Additionally, a sparse data estimation situation was investigated where 500 datasets of 600 subjects each (150 per dose) were generated consisting of 4 random time point samples in 24 hours per subject, using a first-order absorption, 1-compartment disposition, linear elimination model.
Source
Schoemaker R, Xiong Y, Wilkins J, Laveille C, Wang W. nlmixr2: an open-source package for pharmacometric modelling in R. ACOP 2016
See Also
Other nlmixr2 datasets: 
Bolus_1CPTMM,
Bolus_1CPT,
Bolus_2CPTMM,
Bolus_2CPT,
Infusion_1CPTMM,
Infusion_2CPTMM,
Infusion_2CPT,
Oral_1CPTMM,
Oral_1CPT,
Oral_2CPTMM,
Oral_2CPT,
Wang2007,
mavoglurant,
nimoData,
nmtest,
pheno_sd,
rats,
theo_md,
theo_sd,
warfarin,
wbcSim
1 Compartment Model w/MM elimination Simulated Data from ACOP 2016
Description
This is a simulated dataset from the ACOP 2016 poster. All Datasets were simulated with the following methods.
Usage
Infusion_1CPTMM
Format
A data frame with 7,920 rows and 14 columns
- ID
 Simulated Subject ID
- TIME
 Simulated Time
- DV
 Simulated Dependent Variable
- LNDV
 Simulated log(Dependent Variable)
- MDV
 Missing DV data item
- AMT
 Dosing AMT
- EVID
 NONMEM Event ID
- DOSE
 Dose
- V
 Individual Simulated Volume
- KM
 Individual Km constant
- VM
 Individual Vm constant
- SD
 Single Dose Flag
- RATE
 NONMEM Rate
- CMT
 Compartment
Details
Richly sampled profiles were simulated for 4 different dose levels (10, 30, 60 and 120 mg) of 30 subjects each as single dose (over 72h), multiple dose (4 daily doses), single and multiple dose combined, and steady state dosing, for a range of test models: 1- and 2-compartment disposition, with and without 1st order absorption, with either linear or Michaelis-Menten (MM) clearance(MM without steady state dosing). This provided a total of 42 test cases. All inter-individual variabilities (IIVs) were set at 30%, residual error at 20% and overlapping PK parameters were the same for all models. A similar set of models was previously used to compare NONMEM and Monolix4. Estimates of population parameters, standard errors for fixed-effect parameters, and run times were compared both for closed-form solutions and using ODEs. Additionally, a sparse data estimation situation was investigated where 500 datasets of 600 subjects each (150 per dose) were generated consisting of 4 random time point samples in 24 hours per subject, using a first-order absorption, 1-compartment disposition, linear elimination model.
Source
Schoemaker R, Xiong Y, Wilkins J, Laveille C, Wang W. nlmixr2: an open-source package for pharmacometric modelling in R. ACOP 2016
See Also
Other nlmixr2 datasets: 
Bolus_1CPTMM,
Bolus_1CPT,
Bolus_2CPTMM,
Bolus_2CPT,
Infusion_1CPT,
Infusion_2CPTMM,
Infusion_2CPT,
Oral_1CPTMM,
Oral_1CPT,
Oral_2CPTMM,
Oral_2CPT,
Wang2007,
mavoglurant,
nimoData,
nmtest,
pheno_sd,
rats,
theo_md,
theo_sd,
warfarin,
wbcSim
2 Compartment Model with Infusion Simulated Data from ACOP 2016
Description
This is a simulated dataset from the ACOP 2016 poster. All Datasets were simulated with the following methods.
Usage
Infusion_2CPT
Format
A data frame with 7,920 rows and 17 columns
- ID
 Simulated Subject ID
- TIME
 Simulated Time
- DV
 Simulated Dependent Variable
- LNDV
 Simulated log(Dependent Variable)
- MDV
 Missing DV data item
- AMT
 Dosing AMT
- EVID
 NONMEM Event ID
- DOSE
 Dose
- V
 Individual Simulated Volume
- CL
 Individual Clearance
- Q
 Individual Inter-compartmental Clearance
- V2
 Individual Peripheral Volume
- SS
 Steady State
- RATE
 NONMEM Rate
- II
 Interdose Interval
- SD
 Single Dose Flag
- CMT
 Compartment
Details
Richly sampled profiles were simulated for 4 different dose levels (10, 30, 60 and 120 mg) of 30 subjects each as single dose (over 72h), multiple dose (4 daily doses), single and multiple dose combined, and steady state dosing, for a range of test models: 1- and 2-compartment disposition, with and without 1st order absorption, with either linear or Michaelis-Menten (MM) clearance(MM without steady state dosing). This provided a total of 42 test cases. All inter-individual variabilities (IIVs) were set at 30%, residual error at 20% and overlapping PK parameters were the same for all models. A similar set of models was previously used to compare NONMEM and Monolix4. Estimates of population parameters, standard errors for fixed-effect parameters, and run times were compared both for closed-form solutions and using ODEs. Additionally, a sparse data estimation situation was investigated where 500 datasets of 600 subjects each (150 per dose) were generated consisting of 4 random time point samples in 24 hours per subject, using a first-order absorption, 1-compartment disposition, linear elimination model.
Source
Schoemaker R, Xiong Y, Wilkins J, Laveille C, Wang W. nlmixr2: an open-source package for pharmacometric modelling in R. ACOP 2016
See Also
Other nlmixr2 datasets: 
Bolus_1CPTMM,
Bolus_1CPT,
Bolus_2CPTMM,
Bolus_2CPT,
Infusion_1CPTMM,
Infusion_1CPT,
Infusion_2CPTMM,
Oral_1CPTMM,
Oral_1CPT,
Oral_2CPTMM,
Oral_2CPT,
Wang2007,
mavoglurant,
nimoData,
nmtest,
pheno_sd,
rats,
theo_md,
theo_sd,
warfarin,
wbcSim
2 Compartment Model w/MM elimination Simulated Data from ACOP 2016
Description
This is a simulated dataset from the ACOP 2016 poster. All Datasets were simulated with the following methods.
Usage
Infusion_2CPTMM
Format
A data frame with 7,920 rows and 14 columns
- ID
 Simulated Subject ID
- TIME
 Simulated Time
- DV
 Simulated Dependent Variable
- LNDV
 Simulated log(Dependent Variable)
- MDV
 Missing DV data item
- AMT
 Dosing AMT
- EVID
 NONMEM Event ID
- DOSE
 Dose
- Q
 Individual Between Compartment Clearance
- V
 Individual Simulated Volume
- V2
 Individual Peripheral Volume
- KM
 Individual Km constant
- VM
 Individual Vm constant
- SD
 Single Dose Flag
- RATE
 NONMEM Rate
- CMT
 Compartment
Details
Richly sampled profiles were simulated for 4 different dose levels (10, 30, 60 and 120 mg) of 30 subjects each as single dose (over 72h), multiple dose (4 daily doses), single and multiple dose combined, and steady state dosing, for a range of test models: 1- and 2-compartment disposition, with and without 1st order absorption, with either linear or Michaelis-Menten (MM) clearance(MM without steady state dosing). This provided a total of 42 test cases. All inter-individual variabilities (IIVs) were set at 30%, residual error at 20% and overlapping PK parameters were the same for all models. A similar set of models was previously used to compare NONMEM and Monolix4. Estimates of population parameters, standard errors for fixed-effect parameters, and run times were compared both for closed-form solutions and using ODEs. Additionally, a sparse data estimation situation was investigated where 500 datasets of 600 subjects each (150 per dose) were generated consisting of 4 random time point samples in 24 hours per subject, using a first-order absorption, 1-compartment disposition, linear elimination model.
Source
Schoemaker R, Xiong Y, Wilkins J, Laveille C, Wang W. nlmixr2: an open-source package for pharmacometric modelling in R. ACOP 2016
See Also
Other nlmixr2 datasets: 
Bolus_1CPTMM,
Bolus_1CPT,
Bolus_2CPTMM,
Bolus_2CPT,
Infusion_1CPTMM,
Infusion_1CPT,
Infusion_2CPT,
Oral_1CPTMM,
Oral_1CPT,
Oral_2CPTMM,
Oral_2CPT,
Wang2007,
mavoglurant,
nimoData,
nmtest,
pheno_sd,
rats,
theo_md,
theo_sd,
warfarin,
wbcSim
1 Compartment Model with Oral Absorption Simulated Data from ACOP 2016
Description
This is a simulated dataset from the ACOP 2016 poster. All Datasets were simulated with the following methods.
Usage
Oral_1CPT
Format
A data frame with 7,920 rows and 15 columns
- ID
 Simulated Subject ID
- TIME
 Simulated Time
- DV
 Simulated Dependent Variable
- LNDV
 Simulated log(Dependent Variable)
- MDV
 Missing DV data item
- AMT
 Dosing AMT
- EVID
 NONMEM Event ID
- DOSE
 Dose
- V
 Individual Simulated Volume
- CL
 Individual Clearance
- KA
 Individual Ka
- SS
 Steady State
- II
 Interdose Interval
- SD
 Single Dose Flag
- CMT
 Compartment
Details
Richly sampled profiles were simulated for 4 different dose levels (10, 30, 60 and 120 mg) of 30 subjects each as single dose (over 72h), multiple dose (4 daily doses), single and multiple dose combined, and steady state dosing, for a range of test models: 1- and 2-compartment disposition, with and without 1st order absorption, with either linear or Michaelis-Menten (MM) clearance(MM without steady state dosing). This provided a total of 42 test cases. All inter-individual variabilities (IIVs) were set at 30%, residual error at 20% and overlapping PK parameters were the same for all models. A similar set of models was previously used to compare NONMEM and Monolix4. Estimates of population parameters, standard errors for fixed-effect parameters, and run times were compared both for closed-form solutions and using ODEs. Additionally, a sparse data estimation situation was investigated where 500 datasets of 600 subjects each (150 per dose) were generated consisting of 4 random time point samples in 24 hours per subject, using a first-order absorption, 1-compartment disposition, linear elimination model.
Source
Schoemaker R, Xiong Y, Wilkins J, Laveille C, Wang W. nlmixr2: an open-source package for pharmacometric modelling in R. ACOP 2016
See Also
Other nlmixr2 datasets: 
Bolus_1CPTMM,
Bolus_1CPT,
Bolus_2CPTMM,
Bolus_2CPT,
Infusion_1CPTMM,
Infusion_1CPT,
Infusion_2CPTMM,
Infusion_2CPT,
Oral_1CPTMM,
Oral_2CPTMM,
Oral_2CPT,
Wang2007,
mavoglurant,
nimoData,
nmtest,
pheno_sd,
rats,
theo_md,
theo_sd,
warfarin,
wbcSim
1 Compartment Model w/ Oral Absorption & Michaelis-Menten Elimination
Description
This is a simulated dataset from the ACOP 2016 poster. All Datasets were simulated with the following methods.
Usage
Oral_1CPTMM
Format
A data frame with 7,920 rows and 14 columns
- ID
 Simulated Subject ID
- TIME
 Simulated Time
- DV
 Simulated Dependent Variable
- LNDV
 Simulated log(Dependent Variable)
- MDV
 Missing DV data item
- AMT
 Dosing AMT
- EVID
 NONMEM Event ID
- DOSE
 Dose
- KA
 Individual Absorption constant
- V
 Individual Simulated Volume
- VM
 Individual Vm constant
- KM
 Individual Km constant
- SD
 Single Dose Flag
- CMT
 Compartment
Details
Richly sampled profiles were simulated for 4 different dose levels (10, 30, 60 and 120 mg) of 30 subjects each as single dose (over 72h), multiple dose (4 daily doses), single and multiple dose combined, and steady state dosing, for a range of test models: 1- and 2-compartment disposition, with and without 1st order absorption, with either linear or Michaelis-Menten (MM) clearance(MM without steady state dosing). This provided a total of 42 test cases. All inter-individual variabilities (IIVs) were set at 30%, residual error at 20% and overlapping PK parameters were the same for all models. A similar set of models was previously used to compare NONMEM and Monolix4. Estimates of population parameters, standard errors for fixed-effect parameters, and run times were compared both for closed-form solutions and using ODEs. Additionally, a sparse data estimation situation was investigated where 500 datasets of 600 subjects each (150 per dose) were generated consisting of 4 random time point samples in 24 hours per subject, using a first-order absorption, 1-compartment disposition, linear elimination model.
Source
Schoemaker R, Xiong Y, Wilkins J, Laveille C, Wang W. nlmixr2: an open-source package for pharmacometric modelling in R. ACOP 2016
See Also
Other nlmixr2 datasets: 
Bolus_1CPTMM,
Bolus_1CPT,
Bolus_2CPTMM,
Bolus_2CPT,
Infusion_1CPTMM,
Infusion_1CPT,
Infusion_2CPTMM,
Infusion_2CPT,
Oral_1CPT,
Oral_2CPTMM,
Oral_2CPT,
Wang2007,
mavoglurant,
nimoData,
nmtest,
pheno_sd,
rats,
theo_md,
theo_sd,
warfarin,
wbcSim
2 Compartment Model with Oral Absorption Simulated Data from ACOP 2016
Description
This is a simulated dataset from the ACOP 2016 poster. All Datasets were simulated with the following methods.
Usage
Oral_2CPT
Format
A data frame with 7,920 rows and 15 columns
- ID
 Simulated Subject ID
- TIME
 Simulated Time
- DV
 Simulated Dependent Variable
- LNDV
 Simulated log(Dependent Variable)
- MDV
 Missing DV data item
- AMT
 Dosing AMT
- EVID
 NONMEM Event ID
- DOSE
 Dose
- Q
 Individual Inter-compartmental Clearance
- V1
 Individual Simulated Volume
- V2
 Individual Simulated Peripheral Volume
- CL
 Individual Clearance
- KA
 Individual Ka
- SS
 Steady State
- II
 Interdose Interval
- SD
 Single Dose Flag
- CMT
 Compartment
Details
Richly sampled profiles were simulated for 4 different dose levels (10, 30, 60 and 120 mg) of 30 subjects each as single dose (over 72h), multiple dose (4 daily doses), single and multiple dose combined, and steady state dosing, for a range of test models: 1- and 2-compartment disposition, with and without 1st order absorption, with either linear or Michaelis-Menten (MM) clearance(MM without steady state dosing). This provided a total of 42 test cases. All inter-individual variabilities (IIVs) were set at 30%, residual error at 20% and overlapping PK parameters were the same for all models. A similar set of models was previously used to compare NONMEM and Monolix4. Estimates of population parameters, standard errors for fixed-effect parameters, and run times were compared both for closed-form solutions and using ODEs. Additionally, a sparse data estimation situation was investigated where 500 datasets of 600 subjects each (150 per dose) were generated consisting of 4 random time point samples in 24 hours per subject, using a first-order absorption, 1-compartment disposition, linear elimination model.
Source
Schoemaker R, Xiong Y, Wilkins J, Laveille C, Wang W. nlmixr2: an open-source package for pharmacometric modelling in R. ACOP 2016
See Also
Other nlmixr2 datasets: 
Bolus_1CPTMM,
Bolus_1CPT,
Bolus_2CPTMM,
Bolus_2CPT,
Infusion_1CPTMM,
Infusion_1CPT,
Infusion_2CPTMM,
Infusion_2CPT,
Oral_1CPTMM,
Oral_1CPT,
Oral_2CPTMM,
Wang2007,
mavoglurant,
nimoData,
nmtest,
pheno_sd,
rats,
theo_md,
theo_sd,
warfarin,
wbcSim
1 Compartment Model w/ Oral Absorption & Michaelis-Menten Elimination
Description
This is a simulated dataset from the ACOP 2016 poster. All Datasets were simulated with the following methods.
Usage
Oral_2CPTMM
Format
A data frame with 7,920 rows and 14 columns
- ID
 Simulated Subject ID
- TIME
 Simulated Time
- DV
 Simulated Dependent Variable
- LNDV
 Simulated log(Dependent Variable)
- MDV
 Missing DV data item
- AMT
 Dosing AMT
- EVID
 NONMEM Event ID
- DOSE
 Dose
- KA
 Individual Absorption constant
- V1
 Individual Simulated Volume
- V2
 Individual Simulated Perhipheral Volume
- Q
 Individual Inter-compartmental Clearance
- VM
 Individual Vm constant
- KM
 Individual Km constant
- SD
 Single Dose Flag
- CMT
 Compartment
Details
Richly sampled profiles were simulated for 4 different dose levels (10, 30, 60 and 120 mg) of 30 subjects each as single dose (over 72h), multiple dose (4 daily doses), single and multiple dose combined, and steady state dosing, for a range of test models: 1- and 2-compartment disposition, with and without 1st order absorption, with either linear or Michaelis-Menten (MM) clearance(MM without steady state dosing). This provided a total of 42 test cases. All inter-individual variabilities (IIVs) were set at 30%, residual error at 20% and overlapping PK parameters were the same for all models. A similar set of models was previously used to compare NONMEM and Monolix4. Estimates of population parameters, standard errors for fixed-effect parameters, and run times were compared both for closed-form solutions and using ODEs. Additionally, a sparse data estimation situation was investigated where 500 datasets of 600 subjects each (150 per dose) were generated consisting of 4 random time point samples in 24 hours per subject, using a first-order absorption, 1-compartment disposition, linear elimination model.
Source
Schoemaker R, Xiong Y, Wilkins J, Laveille C, Wang W. nlmixr2: an open-source package for pharmacometric modelling in R. ACOP 2016
See Also
Other nlmixr2 datasets: 
Bolus_1CPTMM,
Bolus_1CPT,
Bolus_2CPTMM,
Bolus_2CPT,
Infusion_1CPTMM,
Infusion_1CPT,
Infusion_2CPTMM,
Infusion_2CPT,
Oral_1CPTMM,
Oral_1CPT,
Oral_2CPT,
Wang2007,
mavoglurant,
nimoData,
nmtest,
pheno_sd,
rats,
theo_md,
theo_sd,
warfarin,
wbcSim
Simulated Data Set for comparing objective functions
Description
This is a simulated dataset from Wang2007 where various NONMEM estimation methods (Laplace FO, FOCE with and without interaction) are described.
Usage
Wang2007
Format
A data frame with 20 rows and 3 columns
- ID
 Simulated Subject ID
- Time
 Simulated Time
- Y
 Simulated Value
Source
Table 1 from Wang, Y Derivation of Various NONMEM estimation methods. J Pharmacokinet Pharmacodyn (2007) 34:575-593.
See Also
Other nlmixr2 datasets: 
Bolus_1CPTMM,
Bolus_1CPT,
Bolus_2CPTMM,
Bolus_2CPT,
Infusion_1CPTMM,
Infusion_1CPT,
Infusion_2CPTMM,
Infusion_2CPT,
Oral_1CPTMM,
Oral_1CPT,
Oral_2CPTMM,
Oral_2CPT,
mavoglurant,
nimoData,
nmtest,
pheno_sd,
rats,
theo_md,
theo_sd,
warfarin,
wbcSim
Inverse Guassian absorption model
Description
Inverse Guassian absorption model
Usage
invgaussian
Format
A data frame with 32 rows and 6 columns
- time
 Time of observation
- cp
 Concentration
Source
Figure 9.7 in D'Argenio DZ, Schumitzky A, and Wang X (2009). "ADAPT 5 User's Guide: Pharmacokinetic/Pharmacodynamic Systems Analysis Software".
Mavoglurant PK data
Description
This was used in a full PBPK model. This one was published for mavoglurant (Wendling et al. 2016).
Usage
mavoglurant
Format
A data frame with 2,678 rows by 14 columns
- ID
 Subject ID
- CMT
 Compartment Number
- EVID
 Event ID
- MDV
 Missing DV
- DV
 Dependent Variable, Mavoglurant
- AMT
 Dose Amount Keyword
- TIME
 Time (hr)
- DOSE
 Dose
- OCC
 Occasion
- RATE
 Rate
- AGE
 Age
- SEX
 Sex
- WT
 Weight
- HT
 Height
Source
Wendling et al. 2016
See Also
Other nlmixr2 datasets: 
Bolus_1CPTMM,
Bolus_1CPT,
Bolus_2CPTMM,
Bolus_2CPT,
Infusion_1CPTMM,
Infusion_1CPT,
Infusion_2CPTMM,
Infusion_2CPT,
Oral_1CPTMM,
Oral_1CPT,
Oral_2CPTMM,
Oral_2CPT,
Wang2007,
nimoData,
nmtest,
pheno_sd,
rats,
theo_md,
theo_sd,
warfarin,
wbcSim
Parent/Metabolite dataset
Description
Parent/Metabolite dataset
Usage
metabolite
Format
A data frame with 32 rows and 6 columns
- time
 Time of observation
- y1
 Parent Concentration
- y2
 Metabolite Concentration
Source
D'Argenio DZ, Schumitzky A, and Wang X (2009). "ADAPT 5 User's Guide: Pharmacokinetic/Pharmacodynamic Systems Analysis Software".
Nimotuzumab PK data
Description
- ID
 Subject ID
- TIME
 Time (hrs)
- AMT
 Dose Amount Keyword
- RATE
 Rate
- DV
 Dependent Variable, Nimotuzumab
- TAD
 Time After Dose
- CMT
 Compartment Number
- OCC
 Occasion
- MDV
 Missing DV
- EVID
 Event ID
- WGT
 Weight
- BSA
 Body Surface Area
- AGE
 Age
- HGT
 Height
- DOS
 Dose
Usage
nimoData
Format
A data frame with 441 rows by 15 columns
Source
Rodriguez-Vera et al. 2015
See Also
Other nlmixr2 datasets: 
Bolus_1CPTMM,
Bolus_1CPT,
Bolus_2CPTMM,
Bolus_2CPT,
Infusion_1CPTMM,
Infusion_1CPT,
Infusion_2CPTMM,
Infusion_2CPT,
Oral_1CPTMM,
Oral_1CPT,
Oral_2CPTMM,
Oral_2CPT,
Wang2007,
mavoglurant,
nmtest,
pheno_sd,
rats,
theo_md,
theo_sd,
warfarin,
wbcSim
One compartment test dataset showing NONMEM 7.4.3 output
Description
This is a example dataset originally created to show how similar
mrgsolve and NONMEM were (See ).
Usage
nmtest
Format
A data frame with 7,157 rows and 15 columns
- id
 NONMEM id
- time
 NONMEM time
- cp
 NONMEM cp output from 7.4.3
- cmt
 cmt specification 1=depot, 2=central
- amt
 Nonmem dose
- evid
 NONMEM Event ID
- ii
 Interdose Interval
- ss
 Steady state flag
- addl
 Individual Clearance
- rate
 Rate of the infusion
- lagt
 Lag time
- bioav
 Bioavailability
- rat2
 Modeled rate when
mode== 1- dur2
 Duration when
mode== 2- mode
 Mode = 0 is no modification, modeled rate when mode=1 and modeled duration when mode=2
Details
The original dataset was created by Kyle Baron and is composed of
id<100 the id>100 are modifications by Matthew Fidler to
benchmark steady state infusions with lag times and other uncommon
features.
Note that rxode2/nlmixr2 will not always match these behaviors
by default, we choose behaviors that we believe make sense.  There
are options to make rxode2/nlmixr2 behave more like NONMEM.
However behaviors we believe are wrong we do not support.
Author(s)
Kyle Baron & Matthew Fidler
See Also
Other nlmixr2 datasets: 
Bolus_1CPTMM,
Bolus_1CPT,
Bolus_2CPTMM,
Bolus_2CPT,
Infusion_1CPTMM,
Infusion_1CPT,
Infusion_2CPTMM,
Infusion_2CPT,
Oral_1CPTMM,
Oral_1CPT,
Oral_2CPTMM,
Oral_2CPT,
Wang2007,
mavoglurant,
nimoData,
pheno_sd,
rats,
theo_md,
theo_sd,
warfarin,
wbcSim
Single Dose Phenobarbitol PK/PD
Description
This is from a PK study in neonatal infants. They received multiple doses of phenobarbital for seizure prevention.
Usage
pheno_sd
Format
A data frame with 744 rows and 8 columns
- ID
 Infant ID
- TIME
 Time (hr)
- AMT
 Dose (ug/kg)
- WT
 Weight (kg)
- APGR
 A 5-minute Apgar score to measure infant health
- DV
 The concentration of phenobarbitol in the serum (ug/mL)
- MDV
 If the dependent variable (DV) is missing; 0 for observations, 1 for doses
- EVID
 Event ID
Details
The data were originally given in Grasela and Donn(1985) and are analyzed in Boeckmann, Sheiner and Beal (1994), in Davidian and Giltinan (1995), and in Littell et al. (1996).
Source
Pinheiro, J. C. and Bates, D. M. (2000), Mixed-Effects Models in S and S-PLUS, Springer, New York. (Appendix A.23)
Davidian, M. and Giltinan, D. M. (1995), Nonlinear Models for Repeated Measurement Data, Chapman and Hall, London. (section 6.6)
Grasela and Donn (1985), Neonatal population pharmacokinetics of phenobarbital derived from routine clinical data, Developmental Pharmacology and Therapeutics, 8, 374-383.
Boeckmann, A. J., Sheiner, L. B., and Beal, S. L. (1994), NONMEM Users Guide: Part V, University of California, San Francisco.
Littell, R. C., Milliken, G. A., Stroup, W. W. and Wolfinger, R. D. (1996), SAS System for Mixed Models, SAS Institute, Cary, NC.
See Also
Other nlmixr2 datasets: 
Bolus_1CPTMM,
Bolus_1CPT,
Bolus_2CPTMM,
Bolus_2CPT,
Infusion_1CPTMM,
Infusion_1CPT,
Infusion_2CPTMM,
Infusion_2CPT,
Oral_1CPTMM,
Oral_1CPT,
Oral_2CPTMM,
Oral_2CPT,
Wang2007,
mavoglurant,
nimoData,
nmtest,
rats,
theo_md,
theo_sd,
warfarin,
wbcSim
Pump failure example dataset
Description
The records the number of failures and operation time for groups of 10 pumps.
Usage
pump
Format
A data frame with 10 rows and 5 columns
- y
 Number of pump failures
- t
 Failure Time
- group
 Continuous Operation (=1) or Intermittent Operation(=2)
- ID
 ID for group of 10 pumps
- logtstd
 Centered operation times
Source
References
Gaver, D. P. and O'Muircheartaigh, I. G. (1987), "Robust Empirical Bayes Analysis of Event Rates," Technometrics, 29, 1-15.
Pregnant Rat Diet Experiment
Description
16 pregnant rats have a control diet, and 16 have a chemically treated diet. The litter size for each rat is recorded after 4 and 21 days. This dataset is used in the SAS Probit-model with binomial data, and saved in the nlmixr2 package as rats.
Usage
rats
Format
A data frame with 32 rows and 6 columns
- trt
 Treatment; c= control diet; t=treated diet
- m
 Litter size after 4 days
- x
 Litter size after 21 days
- x1
 Indicator for trt=c
- x2
 Indicator for trt=t
- ID
 Rat ID
Source
References
Weil, C.S., 1970. Selection of the valid number of sampling units and a consideration of their combination in toxicological studies involving reproduction, teratogenesis or carcinogenesis. Fd. Cosmet. Toxicol. 8, 177-182.
Williams, D.A., 1975. The analysis of binary responses from toxicological experiments involving reproduction and teratogenicity. Biometrics 31, 949-952.
McCulloch, C. E. (1994), "Maximum Likelihood Variance Components Estimation for Binary Data," Journal of the American Statistical Association, 89, 330 - 335.
Ochi, Y. and Prentice, R. L. (1984), "Likelihood Inference in a Correlated Probit Regression Model," Biometrika, 71, 531-543.
See Also
Other nlmixr2 datasets: 
Bolus_1CPTMM,
Bolus_1CPT,
Bolus_2CPTMM,
Bolus_2CPT,
Infusion_1CPTMM,
Infusion_1CPT,
Infusion_2CPTMM,
Infusion_2CPT,
Oral_1CPTMM,
Oral_1CPT,
Oral_2CPTMM,
Oral_2CPT,
Wang2007,
mavoglurant,
nimoData,
nmtest,
pheno_sd,
theo_md,
theo_sd,
warfarin,
wbcSim
Multiple dose theophylline PK data
Description
This data set starts with the day 1 concentrations of the theophylline data that is included in the nlme/NONMEM. After day 7 concentrations were simulated with once a day regimen for 7 days (QD).
Usage
theo_md
Format
A data frame with 348 rows by 7 columns
- ID
 Subject ID
- TIME
 Time (hr)
- DV
 Dependent Variable, theophylline concentration (mg/L)
- AMT
 Dose Amount (kg)
- EVID
 rxode2/nlmixr2 event ID (not NONMEM event IDs)
- CMT
 Compartment number
- WT
 Body weight (kg)
Source
NONMEM/nlme
See Also
Other nlmixr2 datasets: 
Bolus_1CPTMM,
Bolus_1CPT,
Bolus_2CPTMM,
Bolus_2CPT,
Infusion_1CPTMM,
Infusion_1CPT,
Infusion_2CPTMM,
Infusion_2CPT,
Oral_1CPTMM,
Oral_1CPT,
Oral_2CPTMM,
Oral_2CPT,
Wang2007,
mavoglurant,
nimoData,
nmtest,
pheno_sd,
rats,
theo_sd,
warfarin,
wbcSim
Multiple dose theophylline PK data
Description
This data set is the day 1 concentrations of the theophylline data that is included in the nlme/NONMEM.
Usage
theo_sd
Format
A data frame with 144 rows by 7 columns
- ID
 Subject ID
- TIME
 Time (hr)
- DV
 Dependent Variable, theophylline concentration (mg/L)
- AMT
 Dose Amount (mg)
- EVID
 rxode2/nlmixr2 event ID (not NONMEM event IDs)
- CMT
 Compartment Number
- WT
 Body weight (kg)
Source
NONMEM/nlme
See Also
Other nlmixr2 datasets: 
Bolus_1CPTMM,
Bolus_1CPT,
Bolus_2CPTMM,
Bolus_2CPT,
Infusion_1CPTMM,
Infusion_1CPT,
Infusion_2CPTMM,
Infusion_2CPT,
Oral_1CPTMM,
Oral_1CPT,
Oral_2CPTMM,
Oral_2CPT,
Wang2007,
mavoglurant,
nimoData,
nmtest,
pheno_sd,
rats,
theo_md,
warfarin,
wbcSim
Warfarin PK/PD data
Description
Warfarin PK/PD data
Usage
warfarin
Format
A data frame with 519 rows and 9 columns
- id
 Patient identifier (n=32)
- time
 Time (h)
- amt
 Total drug administered (mg)
- dv
 Warfarin concentrations (mg/L) or PCA measurement
- dvid
 Dependent identifier Information (cp: Dose or PK, pca: PCA, factor)
- evid
 Event identifier
- wt
 Weight (kg)
- age
 Age (yr)
- sex
 Sex (male or female, factor)
Source
Funaki T, Holford N, Fujita S (2018). Population PKPD analysis using nlmixr2 and NONMEM. PAGJA 2018
References
O'Reilly RA, Aggeler PM, Leong LS. Studies of the coumarin anticoagulant drugs: The pharmacodynamics of warfarin in man. Journal of Clinical Investigation 1963; 42(10): 1542-1551
O'Reilly RA, Aggeler PM. Studies on coumarin anticoagulant drugs Initiation of warfarin therapy without a loading dose. Circulation 1968; 38: 169-177.
See Also
Other nlmixr2 datasets: 
Bolus_1CPTMM,
Bolus_1CPT,
Bolus_2CPTMM,
Bolus_2CPT,
Infusion_1CPTMM,
Infusion_1CPT,
Infusion_2CPTMM,
Infusion_2CPT,
Oral_1CPTMM,
Oral_1CPT,
Oral_2CPTMM,
Oral_2CPT,
Wang2007,
mavoglurant,
nimoData,
nmtest,
pheno_sd,
rats,
theo_md,
theo_sd,
wbcSim
Simulated Friberg Myelosuppression model (Yuan Xiong)
Description
- ID
 Subject ID
- TIME
 Time (hrs)
- RATE
 Rate
- AMT
 Dose Amount Keyword
- DV
 Dependent Variable, WBC
- CMT
 Compartment Number
- V2I
 Input Peripheral Volume
- V1I
 Input Central Volume
- V1I
 Input Clearance
- EVID
 nlmixr2/rxode2 classic evid
Usage
wbcSim
Format
An object of class data.frame with 280 rows and 10 columns.
Source
Simulated Data for WBC pac ddmore model
See Also
Other nlmixr2 datasets: 
Bolus_1CPTMM,
Bolus_1CPT,
Bolus_2CPTMM,
Bolus_2CPT,
Infusion_1CPTMM,
Infusion_1CPT,
Infusion_2CPTMM,
Infusion_2CPT,
Oral_1CPTMM,
Oral_1CPT,
Oral_2CPTMM,
Oral_2CPT,
Wang2007,
mavoglurant,
nimoData,
nmtest,
pheno_sd,
rats,
theo_md,
theo_sd,
warfarin